Navigation Links
Inverness Medical Innovations Declares Dividend on its Series B Convertible Perpetual Preferred Stock
Date:5/22/2009

WALTHAM, Mass., May 22 /PRNewswire-FirstCall/ -- Inverness Medical Innovations, Inc. (NYSE: IMA), a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health management, has declared a dividend of $3.00 per share on its Series B Convertible Perpetual Preferred Stock (NYSE: IMA-PB). The dividend will be paid in shares of Series B stock in an amount per share equal to the quotient of (a) $3.00 divided by (b) 97% of the average of the volume-weighted average price per share of the Series B stock on the New York Stock Exchange for each of the five consecutive trading days ending on the second trading day immediately prior to the record date of the dividend. Inverness will pay cash in lieu of any fractional shares resulting from the dividend. The dividend is payable on July 15, 2009 to holders of record of Series B stock at the close of business on July 1, 2009.

Such payment will cover the amount of all dividends accrued from April 1, 2009 through June 30, 2009.

For more information about Inverness Medical Innovations, please visit our website at http://www.invernessmedical.com.

By developing new capabilities in near-patient diagnosis, monitoring and health management, Inverness Medical Innovations enables individuals to take charge of improving their health and quality of life. Inverness' global leading products and services, as well as its new product development efforts, focus on infectious disease, cardiology, oncology, drugs of abuse and women's health. Inverness is headquartered in Waltham, Massachusetts.


'/>"/>
SOURCE Inverness Medical Innovations, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine news :

1. Inverness Completes Acquisition of Cholestech
2. Inverness Medical Innovations Acquires Bio-Stat Healthcare Group
3. Inverness Medical Innovations Acquires Alere Medical
4. Inverness Medical Innovations Announces Closing of Public Offering
5. Inverness Medical Innovations to Participate at 2007 RBC Healthcare Conference on December 12, 2007
6. Inverness Medical Innovations to Acquire Redwood Toxicology Laboratory
7. Inverness Medical Innovations Enters Into a Definitive Agreement to Acquire Matria Healthcare, Inc.
8. Inverness Medical Innovations to Present at 2008 UBS Global Healthcare Services Conference on February 13, 2008
9. Inverness Medical Innovations Schedules Conference Call for 10:00 a.m. ET February 20, 2008 to Discuss Fourth Quarter 2007 Results
10. Law Offices of Howard G. Smith Announces Investigation on Behalf of Current and Former Employees of Inverness Medical Innovations, Inc. Who Invested in the Inverness Medical Innovations, Inc. Employee Savings Plan
11. Correction: Law Offices of Howard G. Smith Announces Investigation on Behalf of Shareholders of Inverness Medical Innovations, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... 2013 Seva Call (Save-A-Call) has launched ... businesses and connects consumers to the right available professional ... time to handle personal matters than the national and ... from work. So, they really can’t afford the 30 ... available professional. , Now, Detroit residents will be able ...
(Date:5/22/2013)... CA (PRWEB) May 22, 2013 Following ... the fitness franchise Fit Body Boot Camp ... Annual 1,000 lb. Meltdown Challenge starting on June 3rd ... Davidson Centre 601 Durham Street, Kincardine, Ontario.     , Fit ... to inspire and motivate local community residents to lose ...
(Date:5/22/2013)... May 22, 2013 Hypervibe, a leader ... , announced today that the company’s US division will ... and Monday. Military personnel ordering the Hypervibe Performance during ... they show a valid military ID. Non-military customers receive ... values commitment, honor, and integrity. These are values that ...
(Date:5/22/2013)... 2013 Asthma, a disorder that causes ... causes wheezing, shortness of breath, chest tightness and coughing ... muscles surrounding the airways become tight and the lining ... air that can pass. Asthma attacks can last for ... severely restricted. Reuters reports that there is ...
(Date:5/22/2013)... 22, 2013 Patients with type 1 ... have better glycemic control as measured by significantly lower ... condition with insulin injections, according to new findings from ... conducted by Kantar Health . The research was ... (International Society for Pharmacoeconomics and Outcomes Research) in New ...
Breaking Medicine News(10 mins):Health News:Seva Call Revs Its Engines to Launch in Motor City 2Health News:Kincardine Fitness Center Promotes 2nd Annual 1,000 lb. Meltdown Challenge to Fight Obesity With All Proceeds Raised Going to Local Charity 2Health News:Kincardine Fitness Center Promotes 2nd Annual 1,000 lb. Meltdown Challenge to Fight Obesity With All Proceeds Raised Going to Local Charity 3Health News:Hypervibe Whole Body Vibration Offers First-Ever Sale This Memorial Day Weekend 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announce New hCG Diet Plans That May Reduce the Severity of Asthma Attacks 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announce New hCG Diet Plans That May Reduce the Severity of Asthma Attacks 3Health News:Insulin Pump Therapy Provides Better Glycemic Control Among Type 1 Diabetics, According to Kantar Health Research 2Health News:Insulin Pump Therapy Provides Better Glycemic Control Among Type 1 Diabetics, According to Kantar Health Research 3
... is,pursuing its external growth strategy in Italy and the ... development in Italy with the acquisition,of Galileo, a major ... stock lenses under its own brand, which is widely,recognized ... a prescription laboratory in Milan and generates EUR13 million ...
... between father,s, but not mother,s, weight and elevated enzymes ... fathers had early-onset obesity are at increased risk for ... U.S. study. , Researchers evaluated 1,732 children, average age ... long-term study of families in Framingham, Mass. The researchers ...
... 2008 PAHEF is,pleased to join Harvard University,s ... partner in the bi-annual conference,Frontiers of Innovation: 20 ... 31st through today. On Monday evening, the executive,director ... (PAHEF), Mr.,Edward Kadunc, discussed multisector partnerships in tackling ...
... reducing food intake 30% decreased infection-fighting cells , , THURSDAY, April ... remember whether it,s "starve a cold, feed a fever" or ... , A study of deer mice has found that reducing ... system. The findings are published in the May/June issue of ...
... the Stars, The View Hosts Agree: March of Dimes,Fund-raising Walk ... 2008 It doesn,t,matter what you call it, March of ... Babies(SM) will be held the last weekend in April in ... their support to the March of,Dimes work to help moms ...
... Fifth Third Bank,today announced a strategic alliance with ... revenue cycle management services to,the healthcare industry, that ... for healthcare providers. The alliance,will enable Fifth Third ... from,claims to payments -- and integrate the data ...
Cached Medicine News:Health News:Essilor Strengthens its Positions in Italy - Three New Acquisitions in the United States 2Health News:Dads' Early-Onset Obesity Linked to Liver Disease in Kids 2Health News:PAHEF Discusses Neglected Diseases and Disaster Preparedness with Innovative Leaders 2Health News:Eating Less May Hinder Immune System 2Health News:March For Babies Has Celebrity Support -- Now It Needs Yours 2Health News:Fifth Third Bank Teams with Leading Healthcare Providers to Deliver a Claims-to-Payment Business Intelligence Platform 2Health News:Fifth Third Bank Teams with Leading Healthcare Providers to Deliver a Claims-to-Payment Business Intelligence Platform 3
(Date:5/22/2013)... N.Y. , May 22, 2013  MGT Capital ... Company will present at the Second Annual Marcum LLP ... New York City at the Grand ... and Chief Executive Officer, will update investors and answer ... The Company,s presentation is scheduled to begin at ...
(Date:5/22/2013)... MAPLE GROVE, Minn. , May 22, ... today announced the successful completion of its ... (extended-release topiramate), an internally developed program for ... the company,s proprietary formulation technology.  USL255 is ... and reduce fluctuations in topiramate blood levels ...
(Date:5/22/2013)... , May 22, 2013 Hemoglobin A1C ... patients with Type 2 diabetes, while modest improvements ... health outcomes and can lead to substantial healthcare ... the International Society for Pharmacoeconomics and Outcomes Research ... two studies, sponsored by Valeritas, makers of the ...
Breaking Medicine Technology:MGT Capital Investments, Inc. To Present At The Second Annual Marcum LLP MicroCap Conference 2MGT Capital Investments, Inc. To Present At The Second Annual Marcum LLP MicroCap Conference 3MGT Capital Investments, Inc. To Present At The Second Annual Marcum LLP MicroCap Conference 4Upsher-Smith Successfully Completes Phase III Study Of USL255 (Extended-Release Topiramate) For Adjunctive Treatment Of Epilepsy In Patients With Refractory Partial-Onset Seizures 2Upsher-Smith Successfully Completes Phase III Study Of USL255 (Extended-Release Topiramate) For Adjunctive Treatment Of Epilepsy In Patients With Refractory Partial-Onset Seizures 3Upsher-Smith Successfully Completes Phase III Study Of USL255 (Extended-Release Topiramate) For Adjunctive Treatment Of Epilepsy In Patients With Refractory Partial-Onset Seizures 4Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 2Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 3Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 4Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 5Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 6
... designed for more uniform drug ... ... Boston,Scientific Corporation (NYSE: BSX ) today announced comprehensive data ... historically controlled trials, which evaluate,the TAXUS(R) Liberte(R) Paclitaxel-Eluting Stent System in ...
... with Kogenate FS Reduces the,Risk of Joint Damage ... Damage, BERKELEY, Calif., Oct. 10 Bayer ... Drug Administration (FDA) has,approved routine prophylaxis with Kogenate(R) ... bleeding episodes and the risk of,joint damage in ...
Cached Medicine Technology:Taxus Atlas Studies Reinforce Safety and Efficacy of Boston Scientific's Next-Generation Taxus Liberte Stent 2Taxus Atlas Studies Reinforce Safety and Efficacy of Boston Scientific's Next-Generation Taxus Liberte Stent 3Taxus Atlas Studies Reinforce Safety and Efficacy of Boston Scientific's Next-Generation Taxus Liberte Stent 4Taxus Atlas Studies Reinforce Safety and Efficacy of Boston Scientific's Next-Generation Taxus Liberte Stent 5Taxus Atlas Studies Reinforce Safety and Efficacy of Boston Scientific's Next-Generation Taxus Liberte Stent 6FDA Approves Bayer HealthCare's Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A 2FDA Approves Bayer HealthCare's Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A 3FDA Approves Bayer HealthCare's Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A 4FDA Approves Bayer HealthCare's Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A 5
Full Handle Laseredge Implant Blade Knife, 4.0 mm straight. Blade dimension: 15.2 mm x 4.0 mm x 3.0 mm x 1.6 mm....
Full Handle Laseredge Crescent Blade Knife, straight. Blade tip dimension: 12.7 mm x 2.0 mm x 3.8 mm....
Full Handle Laseredge Stab Blade Knife, 45 blade. Blade tip dimension: 8.9 mm x 1.9 mm x 1.9 mm....
Full Handle Laseredge Stab Blade Knife, 15 blade. Blade tip dimension: 11.1 mm x 1.5 mm x 5.7 mm....
Medicine Products: